Dr Joshua Chauvin

Dr Joshua Chauvin is an entrepreneur and psychologist with extensive experience at the intersection of global health, mental health innovation, and strategy. He currently serves as a Senior Consultant on Mental Health Initiatives at MedAccess, where he advises on the organisation’s expansion into mental health market shaping, with a particular focus on improving access to psychotropic medicines and exploring opportunities in digital and psychosocial interventions.

At MedAccess, Joshua provides expert strategic and analytical support to help identify, prioritise and assess high-impact mental health interventions suitable for market-shaping engagement. His work includes supporting a Wellcome Trust-funded initiative on psychotropic medicines, engaging global and regional stakeholders, refining priority medicine catalogues, advising on supplier engagement, and strengthening MedAccess’ pipeline of digital mental health interventions. He also contributes to fundraising and donor engagement related to mental health initiatives.

Previously, Joshua was Chief of Staff and Strategy Lead at Koa Health, where he played a central role in the company’s spin-out from Telefónica and its subsequent investment rounds and acquisitions. He has also held roles at Mindstrong Health, where he worked closely with the former Director of the National Institute of Mental Health (Tom Insel), and the Canadian Mental Health Association, and has advised a range of mental health charities including the Anna Freud Centre, Jack.org and batyr. He has been actively involved in anti-stigma campaigns in Canada and the UK. Joshua also serves as an adviser to EMPOWER, a not-for-profit effort within the Harvard Medical School Mental Health For All Lab dedicated to global dissemination of psychosocial interventions.

Joshua currently serves on the Board of Kokoro, a global mental health social enterprise, and is a board member of the Canadian Rhodes Scholars Fund. He holds a PhD in Experimental Psychology from the University of Oxford, where he was both a Rhodes Scholar and a Canadian Centennial Scholar.